Ratings by H.C. Wainwright (Sara Nik)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2026 | Tvardi Therapeutics Inc | TVRD | New Coverage | Buy (N/A) |
2.89 (2.42) |
-16.26% | Details | |
| 12/8/2025 | Pasithea Therapeutics Corp. | KTTA | New Coverage | Buy (N/A) |
1.13 (0.57) |
-49.56% | Details | |
| 9/10/2025 | Moleculin Biotech | MBRX | Maintain | Buy (Buy) |
|
Details | ||
| 6/9/2025 | Moleculin Biotech | MBRX | New Coverage | Buy (N/A) |
0.67 (2.75) |
310.45% | Details | |
| 5/19/2025 | Curis | CRIS | New Coverage | Buy (N/A) |
2.03 (0.36) |
-82.27% | Details |
